genetics

  • Bio
    Chinese scientists CRISPR a human for the first time

    Chinese scientists CRISPR a human for the first time

    A group of Chinese scientists injected a human being with cells genetically edited using CRISPR-Cas9 technology. This is the first time CRISPR has been used on a fully formed adult human and it’s encouraged a biomedical battle between China and the United States. The scientists from China are hoping the genetically edited cells will help their patient fend off a virulent type of… Read More

  • Bio
    Oral arguments for who owns CRISPR-Cas9 start next month

    Oral arguments for who owns CRISPR-Cas9 start next month

    The date has been set for oral arguments to begin over who owns the patent rights to the gene-editing wonder CRISPR-Cas9. Berkeley’s Jennifer Doudna and her colleague from the Max Planck Institute Emmanuelle Charpentier head to court on December 6th to face off against MIT’s Feng Zhang and present their argument before three US Patent and Trademark Office judges on why… Read More

  • Bio
    Genetics startup Genos wants to pay you for your DNA data

    Genetics startup Genos wants to pay you for your DNA data

    The first whole human genome sequencing cost a whopping $2.7 billion. That didn’t bode well for making any breakthroughs on genetic disorders. Luckily, the cost has dropped dramatically since then, leading to a new breed of consumer genetics startups taking a deeper dive into all the double helix’s that make up you. Genos is one of those startups using a next-generation… Read More

  • Bio
    Gut health startup uBiome has raised $15.5 million and is launching a DNA test for your poop

    Gut health startup uBiome has raised $15.5 million and is launching a DNA test for your poop

    There are a lot of startups looking at your DNA these days but uBiome stands out as unique among them for testing the DNA of microorganisms found in your fecal matter. These bugs have a lot to do with your health and the startup is launching a clinical screening test called SmartGut to sequence the DNA of those microbes. uBiome tells TechCrunch it has also closed on $15.5 million in Series… Read More

  • 23andMe reportedly no longer working on next-gen sequencing

    23andMe reportedly no longer working on next-gen sequencing

    23andMe won’t continue with next-generation DNA sequencing and has reportedly laid off the lab working on the project. About half-a-dozen workers were laid off from the Salt Lake City, Utah-based lab, according to BuzzFeed, which first reported the news. By our own count based on LinkedIn, at least five members of the lab have been let go, including its chief medical officer, Dr. Read More

  • Bio
    23andMe’s Anne Wojcicki has a plan to include better genetic data from people of color

    23andMe’s Anne Wojcicki has a plan to include better genetic data from people of color

    One of the first consumer genetic testing companies, 23andMe says it aims to be at the forefront in gathering genetically diverse data throughout the world. The company just launched a standalone $99 ancestry service today as a way to offer those interested in their genetic lineage the ability to trace ancestors and relatives just by spitting into a tube. Ancestral DNA is something founder… Read More

  • Former Twitter VP Katie Jacobs Stanton takes on CMO role at genomics startup Color

    Former Twitter VP Katie Jacobs Stanton takes on CMO role at genomics startup Color

    Katie Jacobs Stanton has accepted the role of chief marketing officer at genomics startup Color. The former Twitter exec left her role at Twitter in February and considered a number of options before landing at the genetics services company. Read More

  • Bio
    Genetics startup Twist Bioscience is working with Microsoft to store the world’s data in DNA

    Genetics startup Twist Bioscience is working with Microsoft to store the world’s data in DNA

    Twist Bioscience, a startup making and using synthetic DNA to store digital data, just struck a contract with Microsoft and the University of Washington to encode vast amounts of information on synthetic genes. Big data means business and the company able to gather a lot of it is very valuable to investors and stockholders. But that data needs to be stored somewhere and can cost a lot for… Read More

  • Bio
    Citizen scientists, you can now DIY your own DNA analysis with Bento Lab

    Citizen scientists, you can now DIY your own DNA analysis with Bento Lab

    Want to know if you have the “athlete gene” or if you’re actually related to the weirdos who claim you as a family member? Get your collection tubes ready, citizen scientists, Bento Lab’s DIY DNA analysis kit is here and ready for the in-home lab. Normally you’d order a kit somewhere like 23andMe, spit in a tube and mail it off for results in six to eight weeks. Read More

  • For less than $1,000 you can now pull up your entire genome on your smartphone

    For less than $1,000 you can now pull up your entire genome on your smartphone

    Veritas Genetics was one of the first companies to sequence the entire human genome for less than $1,000 in 2015. It’s now taken that technology a step further by delivering the results of your entire genome in an app. To put in context just how radical this is, consider the first attempt at whole human genome sequencing required $3.7 billion to produce in 2001. It wasn’t until… Read More

  • 23andMe and Women’s Health Startup Celmatix Combine Forces To Research Genes Affecting Infertility

    23andMe and Women’s Health Startup Celmatix Combine Forces To Research Genes Affecting Infertility

    Humans have been having humans for hundreds of thousands of years as part of our genetic drive so it seems counter-Darwinian that some genes might work against our ability to make a baby. But that is exactly what certain genes might be doing, according to women’s health startup Celmatix, and they are now working with 23andMe to hopefully figure out why. Celmatix tries to take the… Read More

  • At-Home Full Genome-Sequencing Is Now Just A Spit Tube Away

    At-Home Full Genome-Sequencing Is Now Just A Spit Tube Away

    DNA sequencing startup Sure Genomics wants to help you learn about your entire genome at the click of a button. Today, the startup opened up an at-home service to the public, enabling consumers to get their full DNA sequence with a single saliva test. Some of the bigger companies in the personal genome space like Knome and Illumina’s Every Genome offer an all-encompassing service for tens… Read More

  • Another $50M Richer, 23andMe Drops Its Price To $99 Permanently. But Will The Average Dude Buy In?

    Another $50M Richer, 23andMe Drops Its Price To $99 Permanently. But Will The Average Dude Buy In?

    Genetics service 23andMe announced some new cash in the bank today with a $50 million raise from Yuri Milner, 23andMe CEO Anne Wojcicki, Google’s Sergey Brin (who also happens to be Wojcicki’s husband), New Enterprise Associates, MPM Capital, and Google Ventures. With today’s new funding also comes the reduction of the price of its genome analysis service to 99 smackers. Read More

  • 23andMe Makes First Acquisition, Nabs CureTogether To Double Down On Crowdsourced Genetic Research

    23andMe Makes First Acquisition, Nabs CureTogether To Double Down On Crowdsourced Genetic Research

    Founded in 2006, 23andMe set out with an ambitious goal: To one day make the human genome searchable by becoming the go-to resource for personal genetic information. Leveraging DNA analysis technology and web-based interactive tools, the company developed a “Personal Genome Service” that allows anyone and everyone to access and better understand their genetic data, including… Read More

  • Cancer-fighting chemical to be added to beer

    We’ve all heard the “red wine is good for you” argument before, but let’s face it; not everyone would choose a glass of red wine over a nice, cold beer. I wouldn’t, at least. Anyway, the actual benefit of drinking red wine comes from a cancer-fighting chemical called resveratrol, which occurs naturally in grapes. The problem with the red wine argument is that… Read More

  • AmpliChip Assay Helps Prescribe Drugs


    It has long been the intention of chemists to develop ways to tailor medicines specifically to peoples’ genetics. While that’s still a long ways off, new developments in pharmacology are opening doors for patients that were previously inconceivable. One such development is the AmpliChip from Roche. It can analyze a person’s genetic makeup and ascertain whether a… Read More